Darbepoetin alfa and chronic kidney disease

N Engl J Med. 2010 Feb 18;362(7):653-4; author reply 655.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anemia / drug therapy*
  • Cerebral Hemorrhage / chemically induced*
  • Cerebral Hemorrhage / mortality
  • Darbepoetin alfa
  • Drug Therapy, Combination
  • Erythropoietin / adverse effects
  • Erythropoietin / analogs & derivatives*
  • Erythropoietin / therapeutic use
  • Female
  • Hematinics / adverse effects*
  • Hematinics / therapeutic use
  • Humans
  • Male
  • Renal Insufficiency, Chronic / complications
  • Stroke / chemically induced
  • Stroke / epidemiology
  • Tissue Plasminogen Activator / adverse effects

Substances

  • Hematinics
  • Erythropoietin
  • Darbepoetin alfa
  • Tissue Plasminogen Activator